We are live on ! Find out more
BCM

Boone Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 86.31%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+86.31%
3 Year Est. Return
+255.12%
5 Year Est. Return
10 Year Est. Return
AUM
$319M
AUM Growth
+$13.6M
Cap. Flow
-$23.2M
Cap. Flow %
-7.27%
Top 10 Hldgs %
80.97%
Holding
20
New
4
Increased
4
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
HQY icon
HealthEquity
HQY
+$20.4M
2
AZN icon
AstraZeneca
AZN
+$19.3M
3
TYRA icon
Tyra Biosciences
TYRA
+$7.32M
4
LIVN icon
LivaNova
LIVN
+$6.91M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.54M

Top Sells

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$18.1M
2
ICLR icon
Icon
ICLR
+$16.8M
3
COGT icon
Cogent Biosciences
COGT
+$13.6M
4
RAPT
RAPT Therapeutics
RAPT
+$9.69M
5
QURE icon
uniQure
QURE
+$8.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1
Medtronic
MDT
$108B
$41.2M 12.93%
428,789
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$6.55B
$33.3M 10.44%
421,236
-114,496
-21% -$8.22M
IONS icon
3
Ionis Pharmaceuticals
IONS
$8.56B
$33.1M 10.37%
417,833
CI icon
4
Cigna
CI
$75.1B
$26.5M 8.33%
96,453
+13,481
+16% +$3.78M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.5B
$24.5M 7.68%
411,880
+83,334
+25% +$4.54M
NBIX icon
6
Neurocrine Biosciences
NBIX
$16.9B
$21.5M 6.76%
151,815
-14,599
-9% -$2.11M
UNH icon
7
UnitedHealth
UNH
$382B
$20.4M 6.4%
61,762
+3,650
+6% +$1.24M
AZN icon
8
AstraZeneca
AZN
$265B
$20.2M 6.35%
+110,101
New +$19.3M
HQY icon
9
HealthEquity
HQY
$8.4B
$19.5M 6.12%
+212,856
New +$20.4M
LIVN icon
10
LivaNova
LIVN
$4.4B
$17.8M 5.58%
288,895
+120,963
+72% +$6.91M
RAPT
11
DELISTED
RAPT Therapeutics
RAPT
$15.9M 5%
470,456
-312,005
-40% -$9.69M
BBIO icon
12
BridgeBio Pharma
BBIO
$15.6B
$14.1M 4.44%
184,963
-275,319
-60% -$18.1M
KOD icon
13
Kodiak Sciences
KOD
$2.6B
$14.1M 4.42%
503,830
-212,047
-30% -$4.34M
TYRA icon
14
Tyra Biosciences
TYRA
$1.88B
$10.5M 3.29%
+398,482
New +$7.32M
WVE icon
15
Wave Life Sciences
WVE
$1.09B
$5.99M 1.88%
+352,144
New +$3.58M
ABEO icon
16
Abeona Therapeutics
ABEO
$358M
-502,854
Closed -$2.66M
CLPT icon
17
ClearPoint Neuro
CLPT
$441M
-283,912
Closed -$6.19M
COGT icon
18
Cogent Biosciences
COGT
$6.72B
-945,042
Closed -$13.6M
ICLR icon
19
Icon
ICLR
$12.6B
-95,832
Closed -$16.8M
QURE icon
20
uniQure
QURE
$3.03B
-147,317
Closed -$8.6M

Similar funds

Boone Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Boone Capital Management held 20 positions worth $319M, up 4.5% from $305M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Boone Capital Management withdrew a net $23.2M in Q4 2025, closing 5 positions and reducing 5 holdings. Its most notable exit was Icon, an estimated $16.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Boone Capital Management opened a new position in HealthEquity worth $19.5M.

  • Boone Capital Management's largest Q4 2025 buy was HealthEquity: 212,856 shares worth $19.5M.
  • Boone Capital Management added most to LivaNova in Q4 2025, an estimated $6.91M increase.
  • Boone Capital Management's biggest Q4 2025 reduction was BridgeBio Pharma, cutting an estimated $18.1M.
  • Boone Capital Management fully exited Icon in Q4 2025, selling an estimated $16.8M.
  • Boone Capital Management's ten largest holdings make up 81% of its $319M portfolio in Q4 2025.
  • Boone Capital Management opened 4 new positions and closed 5 in Q4 2025.
  • Boone Capital Management's portfolio value rose 4.5% quarter-over-quarter to $319M.

Based on Boone Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.